Second cancer risk and mortality in men treated with radiotherapy for stage i seminoma

British Journal of Cancer

Volumn 110, Issue 1, 2014, Pages 256-263

  Horwich, A ^a   Fossa, S D ^b   Huddart, R ^a   Dearnaley, D P ^a   Stenning, S ^c   Aresu, M ^a   Bliss, J M ^a   Hall, E ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

carboplatin; metastasis; radiotherapy; seminoma

Indexed keywords

ABDOMEN; ADULT; ARTICLE; CANCER CENTER; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORWAY; ORGANS AT RISK; PELVIS; PRIORITY JOURNAL; SECOND CANCER; SEMINOMA; SKIN CANCER; STANDARDIZED INCIDENCE RATIO; TESTIS CANCER; UNITED KINGDOM;

ADULT; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; NORWAY; RADIOTHERAPY, ADJUVANT; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 84891859444     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.551     Document Type: Article

References (40)

1. Aparicio J, Maroto P, del Muro XG, Gumà J, Sánchez- Muñoz A, Margel?́ M, Doménech M, Bastús R, Fernández A, López-Brea M, Terrassa J, Meana A, del Prado PM, Sastre J, Satrústegui JJ, Gironés R, Robert L, Germà JR. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group Study. J Clin Oncol (2011) 29(35): 4677-4681.
2. Beard CJ, Travis LB, Chen MH, Arvold ND, Nguyen PL, Martin NE, Kuban DA, Ng AK, Hoffman KE (2013) Outcomes in stage I testicular seminoma: a population-based study of 9193 patients. Cancer 119(15): 2771-2777.
3. Bosl GJ, Patil S (2011) Carboplatin in clinical stage I seminoma: too much and too little at the same time. J Clin Oncol 29(8): 949-952.
4. Chung PW, Daugaard G, Tyldesley S, Panzarella T, Kollmannsberger CK, Gospodarowicz MK, Warde PR (2010) Prognostic factors for relapse in stage I seminoma managed with surveillance: a validation study. J Clin Oncol 28(Suppl): 15s (abstract 4535).
5. Classen J, Schmidberger H, Meisner C, Winkler C, Dunst J, Souchon R, Weissbach L, Budach V, Alberti W, Bamberg M. German Testicular cancer study Group (2004) Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG). Br J Cancer 90(12): 2305-2311.
6. Cummins S, Yau T, Huddart R, Dearnaley D, Horwich A (2010) Surveillance in stage I seminoma patients: a long-term assessment. Eur Urol 57(4): 673-678.
7. Daugaard G, Petersen PM, Rørth M (2003) Surveillance in stage I testicular cancer. APMIS 111(1): 76-83. discussion 83-85
8. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, Køtlum JE, Olafsdóttir E, Pukkala E, Storm HH (2010) NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 49(5): 725-736.
9. Fossa SD, Aass N, Kaalhus O (1989) Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 16(2): 383-388. (Pubitemid 19077203)
10. Fossa SD, Horwich A, Russell JM, Roberts JT, Cullen MH, Hodson NJ, Jones WG, Yosef H, Duchesne GM, Owen JR, Grosch EJ, Chetiyawardana AD, Reed NS, Widmer B, Stenning SP (1999) Optimal planning target volume for stage I testicular seminoma: A Medical Research Council Randomized Trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol 17(4): 1146.
11. Fung C, Fossa SD, Beard CJ, Travis LB (2012) Second malignant neoplasms in testicular cancer survivors. J Natl Compr Cancer Netw 10(4): 545-556.
12. Hamilton C, Horwich A, Easton D, Peckham MJ (1986) Radiotherapy for stage I seminoma testis: results of treatment and complications. Radiother Oncol 6(2): 115-120. (Pubitemid 16089205)
13. Hemminki K, Liu H, Sundquist J (2010) Second cancers after testicular cancer diagnosed after 1980 in Sweden. Ann Oncol 21(7): 1546-1551.
14. Horwich A, Alsanjari N, A'Hern R, Nicholls J, Dearnaley DP, Fisher C (1992) Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 65(5): 775-778.
15. Horwich A, Bell J (1994) Mortality and cancer incidence following radiotherapy for seminoma of the testis. Radiother Oncol 30(3): 193-198. (Pubitemid 24107511)
16. Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, Dearnaley DP (2003) Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21(8): 1513-1523. (Pubitemid 46594104)
17. Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, Stenning SP (2005) Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 23(6): 1200-1208. (Pubitemid 46202277)
18. Martin J, Chung P, Warde P (2006) Treatment options, prognostic factors and selection of treatment in stage I seminoma. Onkologie 29(12): 592-598. (Pubitemid 46005784)
19. Oliver RT, Mead GM, Rustin GJ, Joffe JK, Aass N, Coleman R, Gabe R, Pollock P, Stenning SP (2011) Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). J Clin Oncol 29(8): 957-962.
20. Osswald M, Harlan LC, Penson D, Stevens JL, Clegg LX (2009) Treatment of a population based sample of men diagnosed with testicular cancer in the United States. Urol Oncol 27(6): 604-610.
21. Powles T, Robinson D, Shamash J, Moller H, Tranter N, Oliver T (2008) The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 19(3): 443-447. (Pubitemid 351336907)
22. Richiardi L, Scélo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Kee-Seng C, Jonasson JG, Martos C, Brennan P (2007) Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries. Int J Cancer 120(3): 623-631. (Pubitemid 44969034)
23. Robinson D, Møller H, Horwich A (2007) Mortality and incidence of second cancers following treatment for testicular cancer. Br J Cancer 96(3): 529-533. (Pubitemid 46215229)
24. Swerdlow AJ, Douglas AJ, Huttly SR, Smith PG (1991) Cancer of the testis, socioeconomic status, and occupation. Br J Ind Med 48(10): 670-674.
25. Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, Stierner UK, Ståhl O, Cavallin-Ståhl EK, KleOH, Dahl O, Cohn-Cedermark G (2011) Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish Norwegian testicular cancer study group. J Clin Oncol 29(6): 719-725.
26. Toledano MB, Jarup L, Best N, Wakefield J, Elliott P (2001) Spatial variation and temporal trends of testicular cancer in Great Britain. Br J Cancer 84(11): 1482-1487. (Pubitemid 32579340)
27. Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, Kohler BA, Pukkala E, Lynch CF, Andersson M, Bergfeldt K, Clarke EA, Wiklund T, Stoter G, Gospodarowicz M, Sturgeon J, Fraumeni Jr JF, Boice Jr JD (1997) Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 89(19): 1429-1439. (Pubitemid 27419206)
28. Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice Jr JD, Dores GM, Gilbert ES (2005) Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97(18): 1354-1365. (Pubitemid 41487803)
29. van den Belt-Dusebout AW, Aleman BM, Besseling G, de Bruin ML, Hauptmann M, van 't Veer MB, de Wit R, Ribot JG, Noordijk EM, Kerst JM, Gietema JA, van Leeuwen FE (2009) Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys 75(5): 1420-1429.
30. van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG, Hoekstra HJ, Ouwens GM, Aleman BM, van Leeuwen FE (2007) Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 25(28): 4370-4378. (Pubitemid 350013842)
31. Van den Eeden SK, Weiss NS, Strader CH, Daling JR (1991) Occupation and the occurrence of testicular cancer. Am J Ind Med 19(3): 327-337.
32. van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, Noyon R, Eliel MR, van Kerkhoff EH, Delemarre JF, Somers R (1993) Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. J Clin Oncol 11: 415-424. (Pubitemid 23071036)
33. von der Maase H, Specht L, Jacobsen GK, Jakobsen A, Madsen EL, Pedersen M, Rørth M, Schultz H (1993) Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer 29A(14): 1931-1934. (Pubitemid 23324346)
34. Vossen CY, Horwich A, Daugaard G, van Poppel H, Osanto S (2012) Patterns of care in the management of seminoma stage I: results from a European survey. BJU Int 110(4): 524-531.
35. Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, von der Maase H (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 20(22): 4448-4452. (Pubitemid 35334756)
36. Warde PR, Gospodarowicz MK, Goodman PJ, Sturgeon JF, Jewett MA, Catton CN, Richmond H, Thomas GM, Duncan W, Munro AJ (1993) Results of a policy of surveillance in stage I testicular seminoma. Int J Radiat Oncol Biol Phys 27(1): 11-15. (Pubitemid 23270651)
37. Zagars GK, Babaian RJ (1987) Stage I testicular seminoma: rationale for postorchiectomy radiation therapy. Int J Radiat Oncol Biol Phys 13(2): 155-162. (Pubitemid 17033826)
38. Zagars GK, Ballo MT, Lee AK, Strom SS (2004) Mortality after cure of testicular seminoma. J Clin Oncol 22(4): 640-647. (Pubitemid 41095067)
39. Zagars GK (1996) Management of stage 1 seminoma: radiotherapy. In Testicular Cancer, Investigation and Management, Horwich A (eds) 2nd edn, 99-121. Chapman & Hall Medical: London,Weinheim, New York, Tokyo, Melbourne, Madras.
40. Zwahlen DR, Martin JM, Millar JL, Schneider U (2008) Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma. Int J Radiat Oncol Biol Phys 70(3): 853-858.